Скачать книгу - Cardiovascular Hemodynamics for the Clinician

Patient-controlled personal health records are the key to successful interaction between physician and patient. They form the core for joined-up communication throughout health organizations. Still, the very name is capable of alarming both patient and doctor. Are they reliable? Are they complete? Are they confidential? Where do you access them? For the doctor, additional concerns surround the implementation: how do you include these online tools in your busy schedule? How much will they add to your existing spend on information technology? Can you get paid for doing all this extra work? Now you can find dependable answers to all of these questions. Written by a physician who has developed his own personal health records software for patients and doctors to interact, Personal Health Records: A Guide for Clinicians explains how to get the best from your patient's records and how to put the information to good use, helping both your patient and yourself to a more effective and efficient outcome in any clinical situation. “The author is a clinical academic, patient and pioneer in his field and does a grand job of explaining the ins and outs of PHRs in a non-patronising manner for the non-tech savvy” – From a review published in Health Services Journal by: Dr Emma Stanton, Commonwealth Fund Harkness Fellow and Specialist Registrar at South London and Maudsley NHS Foundation Trust

With a uniquely perspective on the key factors in recovery from eating disorders, this practical guide for patients and clinicians draws from relevant, real-life case studies. Focuses on real-life recovery strategies that involve motivational factors, physical and psychological health, and issues such as self-esteem, body attitude, emotion regulation and social relationships. Draws on extensive qualitative research with more than 80 former sufferers Offers experience-based guidance for professionals assisting clients in their recovery process

Evidence-based interventions are increasingly being required by third-party payers and an evidence-based orientation has come to define ethical practice. This compendium of short, how-to chapters focuses on the programs and interventions to prevent child maltreatment that have the best scientific evidence supporting their effectiveness. Interventions and programs discussed include Cognitive Behavioral Therapy, EMDR, Multisystemic Therapy, Coping Cat, and many more. Busy practitioners will appreciate this book's implementation of evidence-based practices by providing the practical and «what now» rather than using the typical academic approach.

Everything you need to know about the DSM-5 in an organized and concise presentation Providing you with a quick and easy way to get up-to-speed on recent changes to the two main classification systems—DSM-5 Essentials highlights these changes in a logical and systematic manner so that you can easily make the transition from DSM-IV to DSM-5. Author Lourie Reichenberg offers health care providers, instructors, clinicians in practice settings, and office staff who do coding for insurance reimbursement the information they need to do their jobs smoothly and efficiently with coverage of: The twenty classifications of disorders Emerging measures and models The future of diagnosis and treatment planning Matching clients' needs with the best evidence-based treatment Major changes to the DSM-5 such as the replacement of the multiaxial system, the developmental and lifespan approach, and cultural and gender considerations Arranged in the same sequence as the DSM-5, DSM-5 Essentials covers what has changed from the DSM-IV, what these changes mean for diagnosis, and the implication of these changes on the selection of effective, evidence-based treatment.

Some drugs which are not aimed at treating heart disease have nevertheless been found to have profound effects on heart muscle. Cardiotoxicity is one of the major forms of toxicity seen in drugs and it accounts for most drug recalls and delays experienced in regulatory approvals.In recent years a number of non-cardiac blockbuster drugs such as terfenadine have been withdrawn from major markets because of cardiotoxicity concerns, while other drugs have either been withdrawn prior to marketing or required labelling changes that significantly restricted their use. In Cardiotoxicity of Non-Cardiovascular Drugs international experts describe the molecular mechanisms and clinical read-outs of cardiac events induced by a broad variety of noncardiovascular drugs. Particular emphasis is paid to the preclinical screening of drug cardiotoxicity. Topics include: metabolic targets of cardiotoxicity regulatory aspects translating molecular mechanisms into clinical trials structure-activity relationships in arrhythmias by antihistamines and psychoactive drugs cardiovascular toxicity of antitumor drugs cardiovascular toxicities of non-steroidal anti-inflammatory drugs cardiovascular toxicities of antiretroviral therapies Cardiotoxicity of Non-Cardiovascular Drugs is an essential guide to this important area of drug development. It will find a place on the bookshelves of researchers, regulators and students in medicinal chemistry, drug development, pharmacology, pharmacy and cardiovascular disease.